JESSICA HARE: Open Payments
NPI 1801127436 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$166 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $166
Food & beverage: $166
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 2 | $40 |
| Janssen Biotech, Inc. | 1 | $34 |
| Tempus AI, Inc | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: PROVENGE, ERLEADA, XT CDX, KEYTRUDA, GIVLAARI, LYNPARZA.
Industry payments across NY — which companies pay providers there.
